{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-24-000043","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2024-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.579678+00:00","generated_at":"2026-06-07T01:00:26.185233+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clover Health targets Adjusted EBITDA profitability for full-year 2024","bullets":["Targets Adjusted EBITDA profitability for full-year 2024.","CEO Andrew Toy cites strong 2023 Insurance performance and Clover Assistant technology.","Plans to focus on member retention rather than expansion in core markets.","Will issue full-year 2024 guidance at a later date.","Presentation at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-24-000043","json":"https://secwatch.observer/filing/0001801170-24-000043.json","markdown":"https://secwatch.observer/filing/0001801170-24-000043.md","text":"https://secwatch.observer/filing/0001801170-24-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000043/0001801170-24-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000043/clov-20240110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:00:26.185233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}